Annual Accounts Receivable
$39.20 M
+$8.37 M+27.14%
31 December 2023
Summary:
Xeris Biopharma Holdings annual accounts receivable is currently $39.20 million, with the most recent change of +$8.37 million (+27.14%) on 31 December 2023. During the last 3 years, it has risen by +$32.32 million (+470.14%). XERS annual accounts receivable is now at all-time high.XERS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$41.14 M
-$1.30 M-3.07%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly accounts receivable is currently $41.14 million, with the most recent change of -$1.30 million (-3.07%) on 30 September 2024. Over the past year, it has dropped by -$4.83 million (-10.50%). XERS quarterly accounts receivable is now -10.50% below its all-time high of $45.97 million, reached on 30 September 2023.XERS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.1% | -10.5% |
| 3 y3 years | +470.1% | +203.4% |
| 5 y5 years | +100.0% | +4606.9% |
XERS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +470.1% | -10.5% | +203.4% |
| 5 y | 5 years | at high | -10.5% | +4606.9% | |
| alltime | all time | at high | -10.5% |
Xeris Biopharma Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $41.14 M(-3.1%) |
| June 2024 | - | $42.44 M(+13.4%) |
| Mar 2024 | - | $37.41 M(-4.5%) |
| Dec 2023 | $39.20 M(+27.1%) | $39.20 M(-14.7%) |
| Sept 2023 | - | $45.97 M(+52.1%) |
| June 2023 | - | $30.23 M(-2.1%) |
| Mar 2023 | - | $30.86 M(+0.1%) |
| Dec 2022 | $30.83 M(+76.6%) | $30.83 M(+12.0%) |
| Sept 2022 | - | $27.52 M(+6.8%) |
| June 2022 | - | $25.76 M(+10.1%) |
| Mar 2022 | - | $23.38 M(+34.0%) |
| Dec 2021 | $17.46 M | $17.46 M(+28.7%) |
| Sept 2021 | - | $13.56 M(+10.3%) |
| June 2021 | - | $12.29 M(+37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $8.94 M(+30.0%) |
| Dec 2020 | $6.88 M(+46.5%) | $6.88 M(-42.4%) |
| Sept 2020 | - | $11.93 M(+276.2%) |
| June 2020 | - | $3.17 M(+25.3%) |
| Mar 2020 | - | $2.53 M(-46.1%) |
| Dec 2019 | $4.69 M(>+9900.0%) | $4.69 M(+437.0%) |
| Sept 2019 | - | $874.00 K(+5.8%) |
| June 2019 | - | $826.00 K(-77.2%) |
| Mar 2019 | - | $3.63 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2018 | - | $1.73 M(+62.5%) |
| June 2018 | - | $1.06 M(+271.1%) |
| Mar 2018 | - | $287.00 K(-76.1%) |
| Dec 2017 | $1.20 M(+1087.1%) | $1.20 M |
| Dec 2016 | $101.00 K | - |
FAQ
- What is Xeris Biopharma Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual accounts receivable year-on-year change?
- What is Xeris Biopharma Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly accounts receivable year-on-year change?
What is Xeris Biopharma Holdings annual accounts receivable?
The current annual accounts receivable of XERS is $39.20 M
What is the all time high annual accounts receivable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual accounts receivable is $39.20 M
What is Xeris Biopharma Holdings annual accounts receivable year-on-year change?
Over the past year, XERS annual accounts receivable has changed by +$8.37 M (+27.14%)
What is Xeris Biopharma Holdings quarterly accounts receivable?
The current quarterly accounts receivable of XERS is $41.14 M
What is the all time high quarterly accounts receivable for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly accounts receivable is $45.97 M
What is Xeris Biopharma Holdings quarterly accounts receivable year-on-year change?
Over the past year, XERS quarterly accounts receivable has changed by -$4.83 M (-10.50%)